| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911507 | Lung Cancer | 2012 | 7 Pages |
Abstract
ALK-fusion gene was found in 3.7% (15/404) NSCLC cases and advanced disease with this fusion gene was correlated with younger generation. The ALK inhibitor presented in this study is effective in EML4-ALK NSCLC cases. A further study will be necessary to evaluate the clinical effectiveness of this drug.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hideki Kimura, Takahiro Nakajima, Kengo Takeuchi, Manabu Soda, Hiroyuki Mano, Toshihiko Iizasa, Yukiko Matsui, Mitsuru Yoshino, Masato Shingyoji, Meiji Itakura, Makiko Itami, Dai Ikebe, Sana Yokoi, Hajime Kageyama, Miki Ohira, Akira Nakagawara,